Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/43972
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHerlenius, E.-
dc.contributor.authorHeron, S.-
dc.contributor.authorGrinton, B.-
dc.contributor.authorKeay, D.-
dc.contributor.authorScheffer, I.-
dc.contributor.authorMulley, J.-
dc.contributor.authorBerkovic, S.-
dc.date.issued2007-
dc.identifier.citationEpilepsia, 2007; 48(6):1138-1142-
dc.identifier.issn0013-9580-
dc.identifier.issn1528-1167-
dc.identifier.urihttp://hdl.handle.net/2440/43972-
dc.descriptionThe definitive version is available at www.blackwell-synergy.com-
dc.description.abstractSummary: Mutations of the sodium channel subunit gene SCN2A have been described in families with benign familial neonatal-infantile seizure (BFNIS). We describe two large families with BFNIS and novel SCN2A mutations. The families had 12 and 9 affected individuals, respectively, with phenotypes consistent with BFNIS. Two mutations were discovered in SCN2A (E430Q; I1596S). Both families had individuals with neonatal onset but the typical age of onset was in the early infantile period (mean 3.0 months). One mutation positive individual, with an otherwise typical clinical pattern, had seizures beginning at 13 months. Two individuals with SCN2A mutations were identified with seizures in later life. In each family a single individual with infantile seizures was mutation negative and thus represented phenocopies. This study extends the age range of presentation of BFNIS, confirms that neonatal and early infantile onsets are characteristic, and emphasizes the role of molecular diagnosis to confirm the etiology.-
dc.description.statementofresponsibilityEric Herlenius, Sarah E. Heron, Bronwyn E. Grinton, Deborah Keay, Ingrid E. Scheffer, John C. Mulley, Samuel F. Berkovic-
dc.language.isoen-
dc.publisherBlackwell Publishing Inc-
dc.source.urihttp://dx.doi.org/10.1111/j.1528-1167.2007.01049.x-
dc.subjectHumans-
dc.subjectEpilepsy, Benign Neonatal-
dc.subjectSodium Channels-
dc.subjectNerve Tissue Proteins-
dc.subjectElectroencephalography-
dc.subjectPedigree-
dc.subjectDNA Mutational Analysis-
dc.subjectFamily-
dc.subjectAge Factors-
dc.subjectAge of Onset-
dc.subjectPhenotype-
dc.subjectMutation-
dc.subjectAdolescent-
dc.subjectAdult-
dc.subjectAged-
dc.subjectAged, 80 and over-
dc.subjectMiddle Aged-
dc.subjectChild-
dc.subjectInfant-
dc.subjectAustralia-
dc.subjectSweden-
dc.subjectNAV1.2 Voltage-Gated Sodium Channel-
dc.subjectGenetic Carrier Screening-
dc.titleSCN2A mutations and benign familial neonatal-infantile seizures: The phenotypic spectrum-
dc.typeJournal article-
dc.identifier.doi10.1111/j.1528-1167.2007.01049.x-
pubs.publication-statusPublished-
dc.identifier.orcidHeron, S. [0000-0001-8759-6748]-
Appears in Collections:Aurora harvest
Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.